Citigroup - Mylan "buy"
Seite 11 von 19 Neuester Beitrag: 25.04.21 01:35 | ||||
Eröffnet am: | 01.04.08 08:51 | von: buran | Anzahl Beiträge: | 463 |
Neuester Beitrag: | 25.04.21 01:35 | von: Monikacwpm. | Leser gesamt: | 83.840 |
Forum: | Hot-Stocks | Leser heute: | 7 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 8 | 9 | 10 | | 12 | 13 | 14 | ... 19 > |
Herkunft USA
Indizes/Listen NASDAQ 100, S&P 500
Aktienanzahl 530,3 Mio. (Stand: 02.01.13)
Marktkap. 11.813 Mio. €
GrB
PR Newswire
PITTSBURGH, April 3, 2013
PITTSBURGH, April 3, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Acyclovir Ointment USP, 5%. This product is the first generic version of Valeant International's Zovirax® Ointment, which is indicated in the management of initial genital herpes and in limited non-life-threatening mucocutaneous herpes simplex virus infections in immunocompromised patients.
Acyclovir Ointment USP, 5% had U.S. sales of approximately $230 million for the 12 months ending Dec. 31, 2012, according to IMS Health. Mylan is shipping this product immediately.
Currently, Mylan has 178 ANDAs pending FDA approval representing $78.4 billion in annual sales, according to IMS Health. Thirty-five of these pending ANDAs are potential first-to-file opportunities, representing $20.3 billion in annual brand sales, for the 12 months ending June 30, 2012, according to IMS Health.
Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com
SOURCE Mylan Inc.
Quelle: PR Newswire
GrB
..............ganz grosse Kino hier ,buran
....soll jetzt aber keine Abschreckung sein ..denn wer drin ist und oder mit einsteigt ..kann fett von den Rösterkartoffeln abhaben ..MfG buran
Tradegate 318 21,968 € 22,238 € 314 1,23% 14:20:43
Berlin 318 22,005 € 22,27 € 314 1,20% 14:05:42
Düsseldorf 0 22,005 € 22,275 € 0 1,23% 14:05:33
Frankfurt 455 22,005 € 22,277 € 449 1,24% 14:05:27
München 200 22,015 € 22,29 € 200 1,25% 13:35:57
Nasdaq 400 28,21 $ 28,74 $ 300 1,88% 14:05:48
Stuttgart 3.000 21,725 € 22,275 € 3.000 2,53% 14:00:01
GrB
.....ulla ulla oleeeeeee ein Rudei Völlaaaaaaa ät jibt nur ein Rudi Völlaaaaaaaa
2.228.106 shares durch die Tickertafel ..unheimliche Power ..ask-Preis RT: 28,47 USD
Tradegate 8 Stücke durch die Tafel gezaubert
und Frankfurt
Zeit Kurs Stück
08:04:18 21,636 € 610
DAX grün mit 7.682 Zählers ,GrB
PR Newswire
PITTSBURGH, April 9, 2013
PITTSBURGH, April 9, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced today that it will host a conference call and live webcast Thursday, May 2, 2013, at 4:30 p.m. ET, to review the company's financial results for the first quarter, which ended March 31, 2013. Mylan will release its financial results on May 2 after the market closes.
The dial-in number to access the call is 877.402.3913, or 817.382.5964 for international callers. A replay will be available for approximately seven days at 800.585.8367, or 404.537.3406 for international callers, with access pass code 33371489.
To access a live webcast of the call, please log on to Mylan's website (www.mylan.com) at least 15 minutes before the event is scheduled to begin to register and download or install any necessary software. A replay of the webcast will be available on www.mylan.com for approximately seven days.
Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit, do what's right, not what's easy and impact the future through passionate global leadership. We offer a growing portfolio of approximately 1,100 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don't take our word for it. See for yourself. See inside. mylan.com
SOURCE Mylan Inc.
Quelle: PR Newswire
GrB
........SKP +0,85 .....Pott +292,99% .....buran
buran
Tradegate 321 21,751 € 21,863 € 320 0,51% 13:09:36
Berlin 321 21,755 € 21,875 € 319 0,55% 12:53:20
München 200 21,75 € 21,87 € 200 0,55% 12:31:53
Frankfurt 460 21,75 € 21,88 € 458 0,60% 12:54:20
Düsseldorf 460 21,75 € 21,88 € 458 0,60% 12:54:23
Stuttgart 3.000 21,54 € 21,865 € 3.000 1,51% 12:51:25
Nasdaq 300 26,20 $ 28,72 $ 400 9,62% 10:00:01
........Mama DAX dicke grüne 7.845 JOLLYPUNKTE ..buran und MfG
17.04.13 28,10 28,21 27,81 28,02 $ 4.828.219 124 M
GrB
Zeit Kurs Stück
10:31:36 21,96 € 250
10:31:29 21,96 € 450
08:02:09 21,57 € 0
buran und MfG und weitermachen
29,31 $ +0,10% +0,03 $ / In Euro: 22,497 €
gez unter Tränen,buran .......hopshopshopshopshopshopshops ;-)))